Benjamin Ragen is an Editor for the BMC-series and has been the Editor of BMC Pharmacology and Toxicology since 2017.
Before joining BioMed Central, he received his PhD in psychology at University of California at Davis, which was followed by a post-doctoral position at New York University Langone Medical Center and a second post-doctoral position at New York University. Ben’s focus on biological psychology has involved studies on psychoneuroendocrinology, the opiate system, the neurobiology of monogamy in nonhuman primates, and pharmacological treatments for posttraumatic stress disorder.
Dr. Catherine Sherwin is currently an Associate Professor and Chief of the Division of Clinical Pharmacology, Department of Pediatrics, at the University of Utah School of Medicine. She earned her PhD at the University of Otago, Dunedin School of Medicine, New Zealand in Paediatric Clinical Pharmacology in 2007. Dr. Sherwin has expertise and experience in the development of quantitative pharmacometric models for special populations such as neonates, children and pregnant women. Her projects have included basic studies using cell-line and animal models, analytical method development and clinical trials, all with a distinct emphasis on clinical pharmacology and toxicology. Dr. Sherwin joined the Editorial Board as an Associate Editor in 2013 and became a Section Editor for Clinical Pharmacology Section 2015.